Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Shin, Dong Hoon ^a   Chun, Yang Sook ^a   Lee, Kyoung Hwa ^a   Shin, Hyun Woo ^a   Park, Jong Wan ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN ARREST DEFECTIVE 1 PROTEIN; LYSINE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ACYLTRANSFERASE; ARD1A PROTEIN, HUMAN; CALCIUM;

ACETYLATION; AFFINITY CHROMATOGRAPHY; ARTICLE; CALCIUM SIGNALING; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MUTATIONAL ANALYSIS; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR CELL; CELL MOTION; GENE EXPRESSION REGULATION; GENE LIBRARY; METABOLISM; METASTASIS; MUTATION; NEOPLASM; TUMOR CELL LINE; TWO HYBRID SYSTEM;

ACETYLTRANSFERASES; AMINO ACID MOTIFS; CALCIUM; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE LIBRARY; HUMANS; MUTATION; MYOSIN-LIGHT-CHAIN KINASE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 70449379394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007451     Document Type: Article

References (38)

1. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
2. Tohtong R, Phattarasakul K, Jiraviriyakul A, Sutthiphongchai T (2003) Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain. Prostate Cancer Prostatic Dis 6: 212-216.
3. Minamiya Y, Nakagawa T, Saito H, Matsuzaki I, Taguchi K, et al. (2005) Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer. Tumour Biol 26: 153-157.
4. Gillespie GY, Soroceanu L, Manning TJ, Jr., Gladson CL, Rosenfeld SS (1999) Glioma migration can be blocked by nontoxic inhibitors of myosin II. Cancer Res 59: 2076-2082.
5. Kaneko K, Satoh K, Masamune A, Satoh A, Shimosegawa T (2002) Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines. Pancreas 24: 34-41.
6. Gallagher PJ, Herring BP, Stull JT (1997) Myosin light chain kinases. J Muscle Res Cell Motil 18: 1-16.
7. Lazar V, Garcia JG (1999) A single human myosin light chain kinase gene (MLCK; MYLK). Genomics 57: 256-267.
8. Kamm KE, Stull JT (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620.
9. Gallagher PJ, Herring BP, Griffin SA, Stull JT (1991) Molecular characterization of a mammalian smooth muscle myosin light chain kinase. J Biol Chem 266: 23936-23944.
10. Herring BP, Dixon S, Gallagher PJ (2000) Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. Am J Physiol Cell Physiol 279: C1656-C1664.
11. Kamm KE, Stull JT (2001) Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276: 4527-4530.
12. Smith L, Su X, Lin P, Zhi G, Stull JT (1999) Identification of a novel actin binding motif in smooth muscle myosin light chain kinase. J Biol Chem 274: 29433-29438.
13. Smith L, Stull JT (2000) Myosin light chain kinase binding to actin filaments. FEBS Lett 480: 298-300.
14. Adelstein RS, Eisenberg E (1980) Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 49: 921-956.
15. Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P (1992) The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 210: 1023-1035.
16. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, et al. (1994) Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 269: 31598-31606.
17. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, et al. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249.
18. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, et al. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248.
19. Chrzanowska-Wodnicka M, Burridge K (1996) Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133: 1403-1415.
20. Whiteway M, Szostak JW (1985) The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell 43: 483-492.
21. Whiteway M, Freedman R, Van Arsdell S, Szostak JW, Thorner J (1987) The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus. Mol Cell Biol 7: 3713-3722.
22. Lee FJ, Lin LW, Smith JA (1989) N alpha acetylation is required for normal growth and mating of Saccharomyces cerevisiae. J Bacteriol 171: 5795-5802.
23. Park EC, Szostak JW (1992) ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J 11: 2087-2093.
24. Arnesen T, Anderson D, Baldersheim C, Lanotte M, Varhaug JE, et al. (2005) Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J 386: 433-443.
25. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, et al. (2002) Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111: 709-720.
26. Kim SH, Park JA, Kim JH, Lee JW, Seo JH, et al. (2006) Characterization of ARD1 variants in mammalian cells. Biochem Biophys Res Commun 340: 422-427.
27. Lim JH, Park JW, Chun YS (2006) Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 66: 10677-10682.
28. Polevoda B, Sherman F (2000) Nalpha-terminal acetylation of eukaryotic proteins. J Biol Chem 275: 36479-36482.
29. Arnesen T, Kong X, Evjenth R, Gromyko D, Varhaug JE, et al. (2005) Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha. FEBS Lett 579: 6428-6432.
30. Williams AF, Barclay AN (1988) The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 6: 381-405.
31. Einheber S, Fischman DA (1990) Isolation and characterization of a cDNA clone encoding avian skeletal muscle C-protein: an intracellular member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A 87: 2157-2161.
32. Dulyaninova NG, Bresnick AR (2004) The long myosin light chain kinase is differentially phosphorylated during interphase and mitosis. Exp Cell Res 299: 303-314.
33. Matsumura F, Ono S, Yamakita Y, Totsukawa G, Yamashiro S (1998) Specific localization of serine 19 phosphorylated myosin II during cell locomotion and mitosis of cultured cells. J Cell Biol 140: 119-129.
34. Yamazaki D, Kurisu S, Takenawa T (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386.
35. Fajmut A, Brumen M, Schuster S (2005) Theoretical model of the interactions between Ca2+, calmodulin and myosin light chain kinase. FEBS Lett 579: 4361-4366.
36. Lee J, Ishihara A, Oxford G, Johnson B, Jacobson K (1999) Regulation of cell movement is mediated by stretch-activated calcium channels. Nature 400: 382-386.
37. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P (1999) Inhibition of myosin light chain kinase by p21-activated kinase. Science 283: 2083-2085.
38. Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, et al. (2003) Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion. Cancer Res 63: 8700-8707.